PATENT CLAIM ANALYSIS

Application Number: 16204398
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["424", "203100"]

Abstract:
In various aspects, the invention relates to immune tolerant glycosidase therapy. The invention provides methods for treating or preventing infectious disease, including chronic viral infections, and highly contagious infectious agents that present an ongoing challenge for the immune system. The compositions and treatment regimens find use with other antiviral or antimicrobial therapies, as well as in conjunction with vaccination to boost effectiveness and/or extend the duration of protective effect. In certain embodiments, the regimen described herein reduces or eliminates the need for administration of other traditional antiviral or antimicrobial therapies. In various embodiments, the invention finds use in immunocompromised patients to boost immune function.

Claim (Index 21):
The method of any one of  claims 16  to  20 , wherein the glycosidase regimen is administered after at least one round of antibiotic therapy has failed to ameliorate or eliminate the infection.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.57534
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14569501', '14462285', '14321413', '13080109', '14182296']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.739199934892427
- 35 USC 102 Novelty (BERT): 0.5111697924168795
- Combined Prediction Score: 0.7163969206448721
- Mean Citation Score: 238.323452
- Max Citation Score: 258.02826
- Similarity Product: 164.73239743652343

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test